Peptide-dependent vectors have obtained focus for their specificity in binding to receptors overexpressed in breast most cancers cells, probably overcoming troubles relevant to lower internalization. Shorter protein and peptide therapeutics made by genetic code enlargement even have a brief half-everyday living thanks to their poor pharmacokinet